Loading Events

« All Events

  • This event has passed.

Bay Area Life Sciences Roundtable

June 22 @ 1:30 pm - 4:30 pm

Please join Sidley at SFMOMA for the 7th Annual Bay Area Lifesciences Roundtable, an afternoon of provocative discussions addressing cutting-edge trends and hot topics.

We are thrilled to be back together in-person for this year’s event which will be held at a beautiful outdoor space—SFMOMA’s Sculpture Garden.

RSVP

Wednesday, June 22, 2022
1:30 p.m. – 4:30 p.m.
Cocktail reception to follow

Private access to the Fisher Collection and the Contemporary Optics Exhibit will be available during the cocktail reception.


FEATURED PANELS

Additional panelists to be announced.

Hot Topics in Managing Global Supply Chain Issues: Before, During, and After Launch

Gain valuable insights from in-house and former agency counsel who have been in the trenches.

Topics will include:

  • Common global supply chain patterns for pre-commercial and commercial companies
  • How to manage FDA compliance and quality risks associated with global supply chain
  • Evaluating key international reference pricing considerations and trends
  • Analyzing key case study examples

Featured Panelists

Angie Lewis-White, VP Commercial Supply Chain & Contract Manufacturing, Myovant Sciences

Raj Pai, Partner, Food, Drug and Medical Device Compliance and Enforcement; formerly with the FDA’s Office of Chief Counsel and former Special Assistant United States Attorney

Catherine Starks, Partner, Healthcare

Adriana Tibbitts, Partner, Technology and Life Sciences Transactions

 

Operationalizing Diversity for Positive Business and Clinical Results

Diversity is a laudable goal, sufficient in its own right. However, this panel will take the topic a step further, exploring concrete ways that diversity can be used to make and run a better life sciences company.

Topics will include:

  • Examining diversity in clinical trial design and recruitment to lead to better medicines
  • Steps to ensure that market access strategies deliver innovative products to appropriate, but often underserved, groups who would benefit
  • The myriad ways that diversity touches how companies operate, from the board room to the lunch room

Featured Panelists

Stanley LewisMD, Founder and CEO of A28 Therapeutics

Brandon Allgood, Ph.D., Chief Artificial Intelligence Officer, Valo Health

R’Kes Starling, Chief Executive Officer/President, Reveles Clinical Services

Deeona Gaskin, Partner, Food, Drug and Medical Device Compliance and Enforcement

Moderators

Stephen Abreu, Partner, Technology and Life Sciences Transactions

Mustafa Abdul-Jabbar, Managing Associate, Commercial Litigation and Disputes

 

Managing Your Message and Positioning: Navigating Strategic and Disclosure Considerations in Product Development and Launch

Deciding when and how to share non-public information about key events in your company’s life cycle in general and in transactional settings—such as clinical trial results, regulatory meetings, and product launch—raises complex questions at the intersection of SEC, FDA and First Amendment law. Our panel will help you:

  • Understand expectations from key federal regulators, with insights from seasoned practitioners, including former FDA Chief Counsel
  • Track evolving First Amendment protections for truthful and non-misleading commercial and scientific speech
  • Explore real-world scenarios, including: preparing for data release from clinical trials, charting next steps and regulatory pathways, and evaluating public statements about comparative and competitive positioning, regulatory meetings, and feedback
  • Understand the perspectives of seasoned practitioners and in-house counsel about managing disclosures in transactional settings, IPOs, and M&A

Featured Panelists

Heather Turner, former Chief Legal Officer, Lyell Immunopharma, Inc.

Frank Rahmani, Partner, Global Life Sciences and Capital Markets

Becky Wood, Partner, Food, Drug and Medical Device Regulatory and former Chief Counsel, FDA


COVID-19 PROTOCOL

In light of the COVID-19 pandemic, Sidley continues to take precautions to safeguard the health and well-being of our clients, colleagues, and guests. Proof of vaccination is required to attend. Please follow all CDC and local California guidelines. If you are experiencing cold- or flu-like symptoms or if you have been in contact with anyone who has been exposed to or infected with COVID-19 within the past 14 days, we ask that you not attend the event. We appreciate your cooperation and concern for the health and safety of our guests.

Additional guidance will be provided prior to the event and in accordance with CDC and local guidelines.


Who may be interested in attending

Executives, Investors, and Company Counsel

CLE credit for this program is pending.

For more information, contact GlobalLifeSci@sidley.com.

Details

Date:
June 22
Time:
1:30 pm - 4:30 pm

Venue

SFMOMA
147 Minna St. Floor 5
San Francisco, CA 94103 United States
+ Google Map

Details

Date:
June 22
Time:
1:30 pm - 4:30 pm

Venue

SFMOMA
147 Minna St. Floor 5
San Francisco, CA 94103 United States
+ Google Map